{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T22:18:17Z","timestamp":1791929897136,"version":"4.3.4"},"reference-count":49,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T00:00:00Z","timestamp":1769644800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP25ama221333"],"award-info":[{"award-number":["JP25ama221333"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP24gm1210009"],"award-info":[{"award-number":["JP24gm1210009"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007428","name":"Naito Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007428","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019868","name":"Chukyo Longevity Medical and Promotion Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019868","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22K07000"],"award-info":[{"award-number":["22K07000"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22H02848"],"award-info":[{"award-number":["22H02848"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22K18390"],"award-info":[{"award-number":["22K18390"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajp.amjpathol.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Pathology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.ajpath.2026.01.006","type":"journal-article","created":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:27:18Z","timestamp":1770078438000},"page":"1205-1219","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Increased Meflin Expression in Cancer-Associated Fibroblasts Restrains Tumor Cell Proliferation and Shapes Vessel-Rich Stroma in Triple-Negative Breast Cancer"],"prefix":"10.1016","volume":"196","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4508-9005","authenticated-orcid":false,"given":"Akihiro","family":"Sakai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Miyai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukihiro","family":"Shiraki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryota","family":"Ando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobutoshi","family":"Esaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadashi","family":"Iida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Sugie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Shibata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toyone","family":"Kikumori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7302-0278","authenticated-orcid":false,"given":"Norikazu","family":"Masuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1494-7716","authenticated-orcid":false,"given":"Hiroyoshi Y.","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsunobu R.","family":"Kano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9206-6116","authenticated-orcid":false,"given":"Atsushi","family":"Enomoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8266-3235","authenticated-orcid":false,"given":"Shinji","family":"Mii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajpath.2026.01.006_bib1","doi-asserted-by":"crossref","first-page":"252","DOI":"10.5306\/wjco.v6.i6.252","article-title":"Biomarkers in triple negative breast cancer: a review","volume":"6","author":"Yadav","year":"2015","journal-title":"World J Clin Oncol"},{"key":"10.1016\/j.ajpath.2026.01.006_bib2","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1056\/NEJMra1001389","article-title":"Triple-negative breast cancer","volume":"363","author":"Foulkes","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpath.2026.01.006_bib3","doi-asserted-by":"crossref","first-page":"4429","DOI":"10.1158\/1078-0432.CCR-06-3045","article-title":"Triple-negative breast cancer: clinical features and patterns of recurrence","volume":"13","author":"Dent","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ajpath.2026.01.006_bib4","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1056\/NEJMoa1706450","article-title":"Olaparib for metastatic breast cancer in patients with a germline BRCA mutation","volume":"377","author":"Robson","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpath.2026.01.006_bib5","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1056\/NEJMoa1802905","article-title":"Talazoparib in patients with advanced breast cancer and a germline BRCA mutation","volume":"379","author":"Litton","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpath.2026.01.006_bib6","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1158\/1078-0432.CCR-21-3045","article-title":"Phase 1b clinical trial with alpelisib plus olaparib for patients with advanced triple-negative breast cancer","volume":"28","author":"Batalini","year":"2022","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ajpath.2026.01.006_bib7","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s11523-021-00796-4","article-title":"An overview of PARP inhibitors for the treatment of breast cancer","volume":"16","author":"Cortesi","year":"2021","journal-title":"Target Oncol"},{"key":"10.1016\/j.ajpath.2026.01.006_bib8","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/nrc.2016.73","article-title":"The biology and function of fibroblasts in cancer","volume":"16","author":"Kalluri","year":"2016","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ajpath.2026.01.006_bib9","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1158\/2159-8290.CD-19-0094","article-title":"Cross-species single-cell analysis of pancreatic ductal adenocarcinoma reveals antigen-presenting cancer-associated fibroblasts","volume":"9","author":"Elyada","year":"2019","journal-title":"Cancer Discov"},{"key":"10.1016\/j.ajpath.2026.01.006_bib10","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1084\/jem.20162024","article-title":"Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer","volume":"214","author":"\u00d6hlund","year":"2017","journal-title":"J Exp Med"},{"key":"10.1016\/j.ajpath.2026.01.006_bib11","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.ccell.2018.01.011","article-title":"Fibroblast heterogeneity and immunosuppressive environment in human breast cancer","volume":"33","author":"Costa","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ajpath.2026.01.006_bib12","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/cas.15609","article-title":"The heterogeneity of cancer-associated fibroblast subpopulations: their origins, biomarkers, and roles in the tumor microenvironment","volume":"114","author":"Yamamoto","year":"2023","journal-title":"Cancer Sci"},{"key":"10.1016\/j.ajpath.2026.01.006_bib13","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/s41575-019-0115-0","article-title":"Cancer-associated fibroblasts in gastrointestinal cancer","volume":"16","author":"Kobayashi","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.ajpath.2026.01.006_bib14","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1158\/2159-8290.CD-19-1384","article-title":"Single-cell analysis reveals fibroblast clusters linked to immunotherapy resistance in cancer","volume":"10","author":"Kieffer","year":"2020","journal-title":"Cancer Discov"},{"key":"10.1016\/j.ajpath.2026.01.006_bib15","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/s43018-020-0082-y","article-title":"Cancer-associated fibroblast compositions change with breast cancer progression linking the ratio of S100A4+ and PDPN+ CAFs to clinical outcome","volume":"1","author":"Friedman","year":"2020","journal-title":"Nat Cancer"},{"key":"10.1016\/j.ajpath.2026.01.006_bib16","doi-asserted-by":"crossref","first-page":"5367","DOI":"10.1158\/0008-5472.CAN-19-0454","article-title":"Meflin-positive cancer-associated fibroblasts inhibit pancreatic carcinogenesis","volume":"79","author":"Mizutani","year":"2019","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajpath.2026.01.006_bib17","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1038\/s41388-022-02288-9","article-title":"Pharmacologic conversion of cancer-associated fibroblasts from a protumor phenotype to an antitumor phenotype improves the sensitivity of pancreatic cancer to chemotherapeutics","volume":"41","author":"Iida","year":"2022","journal-title":"Oncogene"},{"key":"10.1016\/j.ajpath.2026.01.006_bib18","doi-asserted-by":"crossref","DOI":"10.1038\/srep22288","article-title":"Identification of Meflin as a potential marker for mesenchymal stromal cells","volume":"6","author":"Maeda","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.ajpath.2026.01.006_bib19","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1053\/j.gastro.2020.11.011","article-title":"The balance of stromal BMP signaling mediated by GREM1 and ISLR drives colorectal carcinogenesis","volume":"160","author":"Kobayashi","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ajpath.2026.01.006_bib20","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.202101230","article-title":"Meflin-positive cancer-associated fibroblasts enhance tumor response to immune checkpoint blockade","volume":"5","author":"Miyai","year":"2022","journal-title":"Life Sci Alliance"},{"key":"10.1016\/j.ajpath.2026.01.006_bib21","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/s41416-024-02734-3","article-title":"Synthetic retinoid-mediated preconditioning of cancer-associated fibroblasts and macrophages improves cancer response to immune checkpoint blockade","volume":"131","author":"Owaki","year":"2024","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ajpath.2026.01.006_bib22","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/path.6211","article-title":"Meflin is a marker of pancreatic stellate cells involved in fibrosis and epithelial regeneration in the pancreas","volume":"262","author":"Ando","year":"2024","journal-title":"J Pathol"},{"key":"10.1016\/j.ajpath.2026.01.006_bib23","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.03397-2020","article-title":"Fibroblasts positive for meflin have anti-fibrotic properties in pulmonary fibrosis","volume":"58","author":"Nakahara","year":"2021","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ajpath.2026.01.006_bib24","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/gtc.12855","article-title":"Meflin defines mesenchymal stem cells and\/or their early progenitors with multilineage differentiation capacity","volume":"26","author":"Hara","year":"2021","journal-title":"Genes Cells"},{"key":"10.1016\/j.ajpath.2026.01.006_bib25","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1111\/gtc.13154","article-title":"Meflin\/ISLR is a marker of adipose stem and progenitor cells in mice and humans that suppresses white adipose tissue remodeling and fibrosis","volume":"29","author":"Ishihara","year":"2024","journal-title":"Genes Cells"},{"key":"10.1016\/j.ajpath.2026.01.006_bib26","first-page":"305","article-title":"Meflin\/Islr is a marker of fibroblasts that arise in fibrotic regions after spinal cord injury","volume":"87","author":"Morita","year":"2025","journal-title":"Nagoya J Med Sci"},{"key":"10.1016\/j.ajpath.2026.01.006_bib27","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/s41568-025-00798-8","article-title":"The fibroinflammatory response in cancer","volume":"25","author":"Xiao","year":"2025","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ajpath.2026.01.006_bib28","article-title":"A cancer cell spheroid assay to assess invasion in a 3D setting","volume":"105","author":"Berens","year":"2015","journal-title":"J Vis Exp"},{"key":"10.1016\/j.ajpath.2026.01.006_bib29","first-page":"3337","article-title":"Spheroid assay to measure TGF-\u03b2-induced invasion","volume":"57","author":"Naber","year":"2011","journal-title":"J Vis Exp"},{"key":"10.1016\/j.ajpath.2026.01.006_bib30","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.biomaterials.2018.11.023","article-title":"Pancreatic stellate cells derived from human pancreatic cancer demonstrate aberrant SPARC-dependent ECM remodeling in 3D engineered fibrotic tissue of clinically relevant thickness","volume":"192","author":"Tanaka","year":"2019","journal-title":"Biomaterials"},{"key":"10.1016\/j.ajpath.2026.01.006_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.120077","article-title":"Heterotypic 3D pancreatic cancer model with tunable proportion of fibrotic elements","volume":"251","author":"Tanaka","year":"2020","journal-title":"Biomaterials"},{"key":"10.1016\/j.ajpath.2026.01.006_bib32","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/path.2124","article-title":"A mouse model of basal-like breast carcinoma with metaplastic elements","volume":"211","author":"McCarthy","year":"2007","journal-title":"J Pathol"},{"key":"10.1016\/j.ajpath.2026.01.006_bib33","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2019104063","article-title":"Stromal cell diversity associated with immune evasion in human triple-negative breast cancer","volume":"39","author":"Wu","year":"2020","journal-title":"EMBO J"},{"key":"10.1016\/j.ajpath.2026.01.006_bib34","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/j.ajpath.2012.06.021","article-title":"Epidermal hyperplasia and appendage abnormalities in mice lacking CD109","volume":"181","author":"Mii","year":"2012","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajpath.2026.01.006_bib35","doi-asserted-by":"crossref","first-page":"4101","DOI":"10.1016\/j.csbj.2021.07.014","article-title":"Survival analysis across the entire transcriptome identifies biomarkers with the highest prognostic power in breast cancer","volume":"19","author":"Gy\u0151rffy","year":"2021","journal-title":"Comput Struct Biotechnol J"},{"key":"10.1016\/j.ajpath.2026.01.006_bib36","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/35021093","article-title":"Molecular portraits of human breast tumours","volume":"406","author":"Perou","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.ajpath.2026.01.006_bib37","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1111\/cas.14346","article-title":"Cancer-associated fibroblasts that restrain cancer progression: hypotheses and perspectives","volume":"111","author":"Miyai","year":"2020","journal-title":"Cancer Sci"},{"key":"10.1016\/j.ajpath.2026.01.006_bib38","first-page":"484","article-title":"Possible disease-protective roles of fibroblasts in cancer and fibrosis and their therapeutic application","volume":"84","author":"Shiraki","year":"2022","journal-title":"Nagoya J Med Sci"},{"key":"10.1016\/j.ajpath.2026.01.006_bib39","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/s41586-021-03549-5","article-title":"Cross-tissue organization of the fibroblast lineage","volume":"593","author":"Buechler","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.ajpath.2026.01.006_bib40","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/s41420-019-0169-3","article-title":"CXCR7 signaling promotes breast cancer survival in response to mesenchymal stromal stem cell-derived factors","volume":"5","author":"Al-Toub","year":"2019","journal-title":"Cell Death Discov"},{"key":"10.1016\/j.ajpath.2026.01.006_bib41","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1124\/mol.118.115279","article-title":"The role of ACKR3 in breast, lung, and brain cancer","volume":"96","author":"Neves","year":"2019","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.ajpath.2026.01.006_bib42","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1007\/s10147-020-01771-1","article-title":"YAP promotes self-renewal of gastric cancer cells by inhibiting expression of L-PTGDS and PTGDR2","volume":"25","author":"Bie","year":"2020","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.ajpath.2026.01.006_bib43","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s13046-021-01839-4","article-title":"Targeted eicosanoids profiling reveals a prostaglandin reprogramming in breast cancer by microRNA-155","volume":"40","author":"Kim","year":"2021","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.ajpath.2026.01.006_bib44","doi-asserted-by":"crossref","first-page":"20009","DOI":"10.1073\/pnas.0805171105","article-title":"Role of prostaglandin D2 receptor DP as a suppressor of tumor hyperpermeability and angiogenesis in vivo","volume":"105","author":"Murata","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajpath.2026.01.006_bib45","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/path.4993","article-title":"Lipocalin-type prostaglandin D synthase-derived PGD2 attenuates malignant properties of tumor endothelial cells","volume":"244","author":"Omori","year":"2018","journal-title":"J Pathol"},{"key":"10.1016\/j.ajpath.2026.01.006_bib46","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1161\/ATVBAHA.112.300993","article-title":"Prostaglandin D2-DP signaling promotes endothelial barrier function via the cAMP\/PKA\/Tiam1\/Rac1 pathway","volume":"33","author":"Kobayashi","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ajpath.2026.01.006_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.114277","article-title":"Prostaglandin D2 strengthens human endothelial barrier by activation of E-type receptor 4","volume":"182","author":"Rittchen","year":"2020","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.ajpath.2026.01.006_bib48","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1126\/science.1104819","article-title":"Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy","volume":"307","author":"Jain","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.ajpath.2026.01.006_bib49","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s10456-017-9562-9","article-title":"Tumor angiogenesis and vascular normalization: alternative therapeutic targets","volume":"20","author":"Viallard","year":"2017","journal-title":"Angiogenesis"}],"container-title":["The American Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944026000313?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944026000313?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T10:37:48Z","timestamp":1776767868000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002944026000313"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":49,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S0002944026000313"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpath.2026.01.006","relation":{},"ISSN":["0002-9440"],"issn-type":[{"value":"0002-9440","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increased Meflin Expression in Cancer-Associated Fibroblasts Restrains Tumor Cell Proliferation and Shapes Vessel-Rich Stroma in Triple-Negative Breast Cancer","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajpath.2026.01.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of the American Society for Investigative Pathology.","name":"copyright","label":"Copyright"}]}}